Arthroscopy provides symptom relief and good functional outcomes in patients with hip synovial chondromatosis

关节镜手术可缓解髋关节滑膜软骨瘤患者的症状并获得良好的功能恢复。

阅读:1

Abstract

The purpose of this study was to evaluate clinical presentation, associated pathology and clinical outcomes after arthroscopic treatment of hip synovial chondromatosis (SC). A prospective data registry was queried for patients with SC diagnosis from 2005 to 2012. Surgical indications were intra-articular pain after failure of conservative treatment, labral pathology, chondral damage or loose bodies. All patients had femoroacetabular impingement based on radiographic findings. Patient-centered outcomes were collected before and after surgery. Standard hip arthroscopy techniques were used to address associated pathology. Twenty-three patients met the inclusion criteria. Eleven were males. Mean age was 43.7 years. Mean center-edge angle was 33.7 and alpha angle 73. Radiographs were diagnostic in five patients (23.8%). Magnetic resonance imaging identified loose bodies in 14 (66%). Most patients had an uncountable amount of loose bodies in the central and peripheral compartments. The most common associated pathology was a labral tear (100%) and acetabular cartilage injury (85%). All patients had improvement in range of motion. The average Modified Harris Hip score improved from 62 (pre-op) to 84.8 (post-op). Short-Form 12-PCS improved from 41 to 53. Western Ontario and McMaster Osteoarthritis Index improved from 27.1 to 7.2. Median overall satisfaction was 9.5 (out of 10). Hip arthroscopy with thorough removal of loose bodies and subtotal synovectomy, coupled with an aggressive and early rehabilitation program, was effective in ameliorating symptoms associated with from hip SC, yielding high levels of patient satisfaction and functional outcomes, in a 2.5 year follow-up time. LEVEL OF EVIDENCE: IV (case series).

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。